Standard Biotools (LAB) EBT Growth (5y) (2015 - 2026)
Standard Biotools (LAB) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | Standard Biotools | 251.69 Mn | -225.03 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.89% |
| Mar 31, 2026 | 6.54% |
| Dec 31, 2025 | 18.74% |
| Sep 30, 2025 | -39.44% |
| Jun 30, 2025 | -5.24% |
| Mar 31, 2025 | -7.11% |
| Dec 31, 2024 | 38.97% |
| Sep 30, 2024 | -9.18% |
| Jun 30, 2024 | -11.27% |
| Mar 31, 2024 | -4.73% |
| Dec 31, 2023 | 23.83% |
| Sep 30, 2023 | -6.17% |
| Jun 30, 2023 | -0.36% |
| Mar 31, 2023 | -2.82% |
| Dec 31, 2022 | 75.75% |
| Sep 30, 2022 | -12.56% |
| Jun 30, 2022 | -29.69% |
| Mar 31, 2022 | -32.27% |
| Sep 30, 2021 | -21.59% |
| Jun 30, 2021 | -14.20% |